Cervical cancer causes, risk factors, and prevention. Citologias atencion primaria teresa rodenas herranz 6. Estimation of savings of lifeyears and cost from early detection of cervical cancer. The early detection of intraepithelial lesions of the cervix through the periodic examination of cervical cells has been fundamental for the prevention of invasive cervical cancer and its related mortality. These changes can be detected by the pap test and treated to prevent cancer from developing. Carcinoma, uterine cervix, treatment, surgery, radiotherapy, prognostic factors. Opportunistic cervical cancer screening can lead to suboptimal screening coverage. Download as pptx, pdf, txt or read online from scribd. Severalrisk factors increase your chance of developing cervical cancer. But having a risk factor, or even several, does not mean that you will get the disease. If you continue browsing the site, you agree to the use of cookies on this website.
The impact of cervical cancer screening programmes in the target population has resulted in an important decline of the disease burden. Extension to the uterine corpus is table 1 figo staging of cancer of the cervix uteri 2018. Underscreened women remain overrepresented in the pool of. Screening of cervical cancer in catalonia 20062012 ncbi. Most cervical cancers start in the cells lining the cervix. Iiic1 pelvic lymph node metastasis only iiic2 paraaortic lymph node metastasis iv the carcinoma has extended beyond the true pelvis or has involved biopsy proven the mucosa of the bladder or rectum. Prediction of cervical intraepithelial neoplasia grade 2.
Cervical cancer is a frequently diagnosed cancer in women worldwide. Women without any of these risk factors rarely develop cervical cancer. Instead, the normal cells of the cervix first gradually develop precancerous changes that may turn into cancer. In this report, we summarise the cervical cancer screening activities carried. Screening of cervical cancer in catalonia 20062012. Jan 26, 2012 a protocol for cervical cancer screening among sexually active women 25 to 65 years of age was introduced in 2006 in catalonia, spain to increase coverage and to recommend a 3yearinterval between screening cytology. We analysed the screening history in the 10 years preceding the study entry in women with and without cc during 20002011. Hpv was tested in 920 women and cervical cytology in all 76.
Muwonge r, wesley rs, nene bm, shastri ss, jayant k, malvi sg, et al. Evaluation of cytology and visual triage of human papillomaviruspositive women in cervical cancer prevention in india. Analysis of three strategies to increase screening coverage for. A randomised, communitybased clinical trial article pdf available in plos one 121. Invasive cervical cancer icc is the third most common tumor in women worldwide. Cancer of the cervix uteri turk jinekolojik onkoloji. Screening of cervical cancer in catalonia 20062012 ecancer. Audit of women with invasive cervical cancer cc is critical for quality control within screening activities. The overall survival, apart from the therapeutic modality, was better than the ones reported on the literature. The local recurrent of cervical cancer was less than the one showed by other authors.
522 1119 1016 1311 374 461 210 962 1222 714 1538 709 1090 449 1593 339 384 1293 1082 869 864 556 721 434 714 1360 1416 139 763 124 557 786 1221 1475 744 168 610 1455